An Economic Evaluation of the 2003 European Society of Hypertension–European Society of Cardiology Guidelines for the Management of Mild-to-Moderate Hypertension in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H., Niakas, Dimitris A.

Volltext

P-606: Efficacy and costs of treatment of mild-to-moderate uncomplicated hypertension in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H.

Volltext

P-649: Rosiglitazone lowers C-reactive protein levels in hypertensive type 2 diabetic patients von Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Stafilas, Panagiotis C., Makedou-Kourti, Kali, Zebekakis, Pantelis, Diamantopoulos, Athanasios, Tourkantonis, Achilleas

Volltext

P-607: Pharmacoeconomic analysis of antihypertensive agents in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H., Zouka, Maria D.

Volltext

Efficacy and costs of treatment of mild-to-moderate uncomplicated hypertension in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H.

Volltext

Pharmacoeconomic analysis of antihypertensive agents in Greece von Stafilas, Panagiotis C., Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Aletras, Vassilios H., Zouka, Maria D.

Volltext

Rosiglitazone lowers C-reactive protein levels in hypertensive type 2 diabetic patients von Sarafidis, Panteleimon A., Lasaridis, Anastasios N., Stafilas, Panagiotis C., Makedou-Kourti, Kali, Zebekakis, Pantelis, Diamantopoulos, Athanasios, Tourkantonis, Achilleas

Volltext